Cite
Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1.
MLA
Oswald, Stefan, et al. “Disposition of Ezetimibe Is Influenced by Polymorphisms of the Hepatic Uptake Carrier OATP1B1.” Pharmacogenetics, vol. 18, no. 7, July 2008, pp. 559–68. EBSCOhost, https://doi.org/10.1097/FPC.0b013e3282fe9a2c.
APA
Oswald, S., König, J., Lütjohann, D., Giessmann, T., Kroemer, H. K., Rimmbach, C., Rosskopf, D., Fromm, M. F., & Siegmund, W. (2008). Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1. Pharmacogenetics, 18(7), 559–568. https://doi.org/10.1097/FPC.0b013e3282fe9a2c
Chicago
Oswald, Stefan, Jörg König, Dieter Lütjohann, Thomas Giessmann, Heyo K. Kroemer, Christian Rimmbach, Dieter Rosskopf, Martin F. Fromm, and Werner Siegmund. 2008. “Disposition of Ezetimibe Is Influenced by Polymorphisms of the Hepatic Uptake Carrier OATP1B1.” Pharmacogenetics 18 (7): 559–68. doi:10.1097/FPC.0b013e3282fe9a2c.